Literature DB >> 17044135

Access to diagnostic evaluation and treatment for dementia in Europe.

Gunhild Waldemar1, Kieu T T Phung, Alistair Burns, Jean Georges, Finn Ronholt Hansen, Steven Iliffe, Christine Marking, Marcel Olde Rikkert, Jacques Selmes, Gabriela Stoppe, Norman Sartorius.   

Abstract

This paper reviews and discusses existing barriers to diagnosis and treatment for patients with dementia in Europe as well as approaches to overcome these barriers. The barriers to care are manifold, being present at all levels in each society and between countries in Europe. Multilevel and multifaceted strategies are needed to improve diagnosis and treatments for all patients with cognitive complaints. A multidisciplinary approach based on close collaboration between GPs and specialised memory clinics may be the ideal model for early accurate diagnosis and subsequently early pharmacological and psychosocial interventions. For all healthcare professionals, there should be specialised training in dementia and frequently updated practice guidelines to provide the framework for standards of care. Culture-sensitive strategies to promote public knowledge and destigmatize dementia are essential. Policy makers and authorities should be made aware of the benefits of early access to diagnosis and treatment. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17044135     DOI: 10.1002/gps.1652

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  32 in total

Review 1.  Dementia case management effectiveness on health care costs and resource utilization: a systematic review of randomized controlled trials.

Authors:  C Pimouguet; T Lavaud; J F Dartigues; C Helmer
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Alzheimer disease: Perceived efficacy of antidementia drug treatment.

Authors:  Kevina McAvinchey; Alistair Burns
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

3.  The use of neuroimaging in dementia by Irish general practitioners.

Authors:  A S Ciblis; M-L Butler; A L W Bokde; P G Mullins; J P McNulty
Journal:  Ir J Med Sci       Date:  2015-06-06       Impact factor: 1.568

Review 4.  [Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].

Authors:  H-J Gertz; A Kurz
Journal:  Nervenarzt       Date:  2011-09       Impact factor: 1.214

5.  Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment: Results From the Gait and Brain Study.

Authors:  Manuel M Montero-Odasso; Yanina Sarquis-Adamson; Mark Speechley; Michael J Borrie; Vladimir C Hachinski; Jennie Wells; Patricia M Riccio; Marcelo Schapira; Ervin Sejdic; Richard M Camicioli; Robert Bartha; William E McIlroy; Susan Muir-Hunter
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

6.  National Dementia Strategy: well intentioned--but how well founded and how well directed?

Authors:  Ian Greaves; David Jolley
Journal:  Br J Gen Pract       Date:  2010-03       Impact factor: 5.386

Review 7.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

Review 8.  Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systematic review.

Authors:  Tamar Koch; Steve Iliffe
Journal:  BMC Fam Pract       Date:  2010-07-01       Impact factor: 2.497

9.  Effects of general practitioner training and family support services on the care of home-dwelling dementia patients--results of a controlled cluster-randomized study.

Authors:  Carolin Donath; Elmar Grässel; Maria Grossfeld-Schmitz; Petra Menn; Jörg Lauterberg; Sonja Wunder; Peter Marx; Stephan Ruckdäschel; Hilmar Mehlig; Rolf Holle
Journal:  BMC Health Serv Res       Date:  2010-11-18       Impact factor: 2.655

Review 10.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.